Skip to main content
eScholarship
Open Access Publications from the University of California

University Honors

University Honors bannerUC Riverside

About

University Honors stimulates lifelong development of the mind through continuous learning and the application of knowledge.  Successful graduates produce original, scholarly, capstone projects and think deeply and critically, in collaboration with others, to solve complex problems using interdisciplinary approaches. [more]

University Honors

There are 833 publications in this collection, published between 2017 and 2024.
UCR Honors Capstones 2016-2017 (66)
63 more worksshow all
UCR Honors Capstones 2017-2018 (77)
74 more worksshow all
UCR Honors Capstones 2018-2019 (70)
67 more worksshow all
UCR Honors Capstones 2019-2020 (106)
103 more worksshow all
UCR Honors Capstones 2020-2021 (121)
118 more worksshow all
UCR Honors Capstones 2021-2022 (144)
141 more worksshow all
UCR Honors Capstones 2022-2023 (118)
115 more worksshow all
UCR Honors Capstones 2023-2024 (112)

DELIVERY OF NEUREGULIN-1 THROUGH AN OSMOTIC TRANSPORT DEVICE (OTD)

In traumatic brain injury (TBI), secondary injury involving neurological damage andedema negatively impacts recovery outcomes. Previous studies have shown that an osmotictransport device (OTD) significantly decreases severe TBI edema in rodent models. Because theOTD requires a craniectomy for direct contact to the brain, it is expected that the simultaneousdelivery of the neuroprotective drug, neuregulin-1 (NRG-1), may further improve neurologicaloutcomes. However, the release rate of NRG-1 must be controlled. In addition, becausehydrogel-drug interactions can be highly complex and impact overall delivery, the release ofNRG-1 from hydrogel must be analyzed. Previous research has shown that hydroxyethylcellulose (HEC) may have the appropriate properties for this purpose. Here we test the release ofthe active EGF-like domain of NRG-1 from a hydrogel made up of 1.5%, 2.0%, and 2.5% HECand artificial cerebrospinal fluid. Concentrations of the EGF domain are measured via anenzyme-linked immunosorbent assay. The results show concentration dependent Fickiandiffusion behavior, with 2.0% HEC being the most promising of the hydrogels tested.Ultimately, the controlled delivery of NRG-1 integrated with an OTD will greatly improverecovery outcomes for victims of severe TBI.

SEROTONIN RECEPTOR MODULATION AS A POSSIBLE TREATMENT FOR AUDITORY HYPERSENSITIVITY IN AN AUTISM SPECTRUM DISORDER

Fragile X syndrome (FXS) is a neurodevelopmental disorder and the leading known geneticcause of autism, resulting from the mutation of the Fmr1 gene which leads to a lack ofproduction of Fragile X Messenger Ribonucleoprotein (FMRP), a key protein in neuronaldevelopment and maintenance. This lack of FMRP results in cognitive deficiencies and sensoryprocessing issues, notably auditory sensitivity which, in its most robust presentation, can induceseizures upon exposure to intense stimulus: Audiogenic seizures (AGS). Previous studies inFmr1 knock-out mice demonstrated that administering NLX-101–a postsynaptic serotonin 1A(5HT1A) agonist reduced AGS. To determine if the specificity of NLX-101 is necessary forreducing AGS, we tested two drugs that more broadly modulate serotonin activity: 8-OH-DPAT,a less specific serotonin 1A agonist that also acts on presynaptic receptors, and Fluoxetine, aserotonin reuptake inhibitor (SSRI) which broadly and non-specifically increases serotoninactivity throughout the brain. Through exposing groups of combined drug-treated and untreatedFmr1 knockout mice to a loud (100-110 dB) modulating sound capable of triggering AGS inuntreated knockout mice, we found no significant differences in the severity of or the latency ofonset for AGS between untreated and drug-treated mice in both 8-OH-DPAT and Fluoxetinetreatments. Our findings indicate that the unique specificity of NLX-101 in modulating serotoninactivity due to only targeting postsynaptic 5-HT1A receptors is necessary to reduce AGS. Theseresults suggest the use of NLX-101, and other specific 5HT1A receptor agonists, as a therapeuticavenue to treat sensory hypersensitivity in FXS and other autisms.

A SOCIAL CONVERSATION ON ASEXUALITY: QUEER SPACES AND MEDIA REPRESENTATION

Asexuality is a sexual orientation in which someone may experience little, situational, or nosexual attraction. From its complicated existence in queer spaces to its complete invisibility insociety and media representation, why does it continue to lack an understanding even as queertopics continue to enter the mainstream conversation? How is this orientation, seeminglystraightforward, shrouded in confusion, mystification, and false stereotypes? As an asexual andaromantic woman, I believe that the cultural obsession with glamorizing sex and romance andportraying it as essential to a fulfilling life plays a part in confusing the general public on howone could live without the desire to participate fully or at all with these cultural norms andexpectations. To better represent these points and how they affect the lives of asexual people ofvarying intersecting identities, I intend to use an ethnographic approach in this study to betterunderstand these shared experiences and the diversity of the asexual subjectivity. My researchengages with an individual method, including descriptive survey, interview, interaction, andobservation, especially participant observation. My aim in this research is to establish a dialogueon asexuality for a better understanding of an orientation underdeveloped in theory. I identifythis as an opportunity to examine and better understand the spectrum of sexuality. In general, Iintend to interrogate the ways the mainstream norm of sexuality itself still seeps into media andqueer spaces and how to further encourage new forms of asexual inclusivity and acceptance invarious areas of society.

109 more worksshow all